Altamira Therapeutics Ltd. — F-1 Filings
17 F-1 filings on record
This page lists all F-1 filings submitted to the SEC by Altamira Therapeutics Ltd. (CYTOF), sorted by most recent first. Each row links to the full filing on EdgarLookup. Altamira Therapeutics Ltd. has filed 17 F-1 documents with the SEC since 2014. To view all SEC filings by Altamira Therapeutics Ltd., see the full filings list.
All
15-12G
15F-12B
20-F
20-F/A
25-NSE
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-A12B/A
8-K12G3
CERT
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-4
F-4/A
FWP
NT 20-F
POS AM
POS EX
RW
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| F-1 | REGISTRATION STATEMENT | 0001213900-24-071896 | Aug 22, 2024 | — |
| F-1 | REGISTRATION STATEMENT | 0001213900-24-031737 | Apr 10, 2024 | — |
| F-1 | REGISTRATION STATEMENT | 0001213900-23-049716 | Jun 16, 2023 | — |
| F-1 | REGISTRATION STATEMENT | 0001213900-23-045058 | Jun 1, 2023 | — |
| F-1 | REGISTRATION STATEMENT | 0001213900-23-012310 | Feb 16, 2023 | — |
| F-1 | REGISTRATION STATEMENT | 0001213900-22-080534 | Dec 16, 2022 | — |
| F-1 | REGISTRATION STATEMENT | 0001213900-22-005956 | Feb 8, 2022 | — |
| F-1 | REGISTRATION STATEMEMT | 0001213900-20-010445 | Apr 29, 2020 | — |
| F-1 | REGISTRATION STATEMENT | 0001213900-19-007363 | Apr 30, 2019 | — |
| F-1 | FORM F-1 | 0001144204-19-004218 | Feb 1, 2019 | — |
| F-1 | F-1 | 0001571049-18-000349 | Jun 15, 2018 | — |
| F-1 | FORM F-1 | 0000950103-18-006095 | May 11, 2018 | — |
| F-1 | FORM F-1 | 0000950103-18-003909 | Mar 28, 2018 | — |
| F-1 | FORM F-1 | 0000950103-18-001821 | Feb 9, 2018 | — |
| F-1 | FORM F-1 | 0000950103-17-009932 | Oct 12, 2017 | — |
| F-1 | FORM F-1 | 0001193125-15-140352 | Apr 22, 2015 | — |
| F-1 | F-1 | 0001193125-14-253454 | Jun 27, 2014 | — |